Hero Section

Products

Find the Right Neo7 Pathway for You

Neo7 offers four personalized pathways for cancer, active or complex disease, post-viral or spike-related concerns, and resilience or healthy aging.

Each pathway looks beyond your diagnosis to evaluate what may be happening in your biology now—helping your provider understand your needs and develop a personalized treatment strategy.

Cancer Pathway
CANCER

Personalized Support for Cancer

Neo7 builds on each patient’s cancer diagnosis to identify the molecular alterations and biological pathways that characterize their individual disease.

These findings help guide a personalized, multi-target peptide strategy tailored to each patient’s unique cancer biology. Neo7 prioritizes patient-specific targets and designs peptides intended to help the patient’s own immune system recognize and respond to cancer-specific targets.

Brochure
Active Disease
ACTIVE DISEASE

Personalized Support for Active Disease

Neo7 uses advanced biological and immune-system data to identify abnormal signaling and areas of dysfunction in the body.

This approach is designed to help develop personalized peptide solutions for patients facing complex or active diseases, including autoimmune, neurodegenerative, viral, environmental, and Lyme-related conditions.

A personalized approach based on what is happening in your body today.

Brochure
SPIKEX
SPIKEX

Understanding Molecular Changes After Viral Exposure

SPIKEX analyzes biological signals associated with SARS-CoV-2 (COVID-19) infection and adverse effects following COVID-19 mRNA vaccination, including changes related to RNA activity, protein function, and immune response.

These insights help identify each patient’s unique molecular response and dysregulated pathways, supporting a more personalized approach to care.

Brochure
Resilience
RESILIENCE

Supporting Healthy Aging and Whole-Body Function

As we age, changes in key biological systems can affect how the body functions and increase the risk of age-related health challenges.

Neo7’s Resilience approach focuses on key biological pathways associated with aging and overall health, including:

Brochure
One Patient. Many Options. One Coordinated Strategy.

Individualized Targeted Immunotherapy

ITI-PES + Adjuvant

Healthcare offers many options—conventional medicine, chemotherapy, immunotherapy, medications, functional and integrative care, nutrition, rehabilitation, wellness technologies, and lifestyle support.

The challenge is not finding another option. It is understanding:

  • Which options make sense for your biology—and
  • how should they work together?

Neo7 evaluates your genetic risks, active biological signals, immune profile, symptoms, and health goals to develop a personalized, multi-target peptide strategy.

Rather than choosing one therapy, following a generic protocol, or continually adding to a treatment stack, the Hub Strategy brings the right resources together around the individual patient.

Neo7 may help inform and complement:
  • Conventional and specialist-directed care
  • Cancer and immune-directed treatments
  • Functional and integrative therapies
  • Regenerative and longevity approaches
  • Nutrition, rehabilitation, movement, and lifestyle support
  • Other therapies selected by the patient’s providers

Neo7 does not have to replace what is already working. It helps create a clearer biological strategy for what to target, what to combine, and what to monitor.

Not one treatment for everyone. Not more therapies for the sake of more. The right strategy, built around one patient.

The goal is to help restore healthier signaling, improve function, strengthen resilience, and support the body’s ability to respond over time.

Neo7 is not the whole wheel. It provides personalized biological direction within the patient’s provider-led Hub Strategy.

FAQ

All peptides are produced by a US-based, cGMP-certified facility, fully compliant with FDA quality and safety standards.

They are delivered as intramuscular, intradermal, subcutaneous, intratumoral (cancer) injections, and nebulized intranasal in specific cases, formulated for the individual’s specific biological indication and prescribed by a licensed healthcare provider.

Yes. Each protocol is built on the individual’s molecular data and uses precision-targeted peptide engineering to deliver therapeutic effects at the root level.

The personalized peptides are produced as a lyophilized (freeze-dried) powder and should be stored at -20°C (standard freezer temperature). Keep them frozen until you are ready to reconstitute and use them. When stored at -20°C, the peptides remain stable and viable for up to three years. For long-term storage, peptides can be preserved indefinitely at -80°C (cryostorage).

Once reconstituted, the personalized peptides can be stored in a refrigerator and are stable for up to 30 days.

It is not recommended to leave unmixed peptides at room temperature. They should be placed in a -20°C freezer as soon as possible. If transportation is required, ensure they are kept cool using an ice pack until they can be properly stored.